Papers and Publications:Detection of minimal disease using rearranged immunoglobulin heavy chain genes from intermediate- and high-grade malignant B cell non-Hodgkin's lymphomaN. van Belzen, P.E. Hupkes, D. Doekharan, M. Hoogeveen-Westerveld, L.C.J. Dorssers, M.B. van’t Veer.; LEUKEMIA (1997) 11; p1742-1752.Rearranged immunoglobulin light chain genes as minimal residual disease markers in intermediate- and high-grade malignant B cell non-Hodgkin’s lymphomaM. Hoogeveen-Westerveld, P.E. Hupkes, D. Doekharan, L.C.J. Dorssers, M.B. van’t Veer, N. van Belzen.; LEUKEMIA (1998) 12; p1810-1816.Platelet-bound immunogloblins before and after platelet transfusion: measurement of in vivo bindingM-D Levin, W. de Vries, J. de Veld, D. Doekharan, B. van der Holt, M.B. van’t Veer.; British Journal of Haematology (1999) 104; p397-402Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy. KROL AD, Berenschot HW, Doekharan D, Henzen-Logmans S, van der Holt B, van 't Veer MB.; Radiother Oncol 2001; 58: 251-5.Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients Marie-Christine Béné; Michel Bernier; René Olivier Casasnovas; Gianluigi Castoldi; Dew Doekharan; Bronno van der Holt; Walter Knapp; Petr Lemež; Wolf-Dieter Ludwig; Estella Matutes; Alberto Orfao; Claudia Schoch; Christian Sperling; Mars B. van't Veer.; British Journal of Haematology (2001) 113 Issue 3; p737-745